Gouty Arthritis - Epidemiology Forecast to 2027

Gouty Arthritis - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Gouty Arthritis (Gout) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Gouty Arthritis (Gout) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Gouty Arthritis (Gout) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Gouty Arthritis (Gout) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Gouty Arthritis (Gout) outlook. It also includes the explanation of changing trends of epidemiology outlining the Gouty Arthritis (Gout) scenario.

Gouty Arthritis (Gout) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Gouty Arthritis (Gout) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Gouty Arthritis (Gout) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Gouty Arthritis (Gout) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Gouty Arthritis (Gout)

Key assessments
• Patient Segmentation in Gouty Arthritis (Gout)
• Gouty Arthritis (Gout) Risk & Burden
• Factors driving growth in a specific Gouty Arthritis (Gout) patient population
1. Report Introduction
2. Gouty Arthritis (Gout) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Gouty Arthritis (Gout) in 2017
2.2. Patient Share Distribution of Gouty Arthritis (Gout) in 2027
3. Disease Background and Overview: Gouty Arthritis (Gout)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Gouty Arthritis (Gout) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Gouty Arthritis (Gout) in 7MM – By Countries
5. Epidemiology of Gouty Arthritis (Gout) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.1.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.1.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.1.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.4.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.4.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.4.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.5.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.5.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.5.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.6.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.6.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.6.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.7.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.7.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.7.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.8.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.8.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.8.5. Diagnosed Cases of the Gouty Arthritis (Gout)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Gouty Arthritis (Gout)
5.9.3. Sub-Type Specific cases of the Gouty Arthritis (Gout) *
5.9.4. Sex- Specific Cases of the Gouty Arthritis (Gout) *
5.9.5. Diagnosed Cases of the Gouty Arthritis (Gout)
6. Unmet Needs of the Gouty Arthritis (Gout)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM
Table 2: Total Prevalent/Incident Cases of the Gouty Arthritis (Gout) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Gouty Arthritis (Gout) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Gouty Arthritis (Gout) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Gouty Arthritis (Gout) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Gouty Arthritis (Gout) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Gouty Arthritis (Gout) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Gouty Arthritis (Gout) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Gouty Arthritis (Gout) in France (2016-2027) *
Table 14: Diagnosed Cases of the Gouty Arthritis (Gout) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Gouty Arthritis (Gout) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Gouty Arthritis (Gout) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Gouty Arthritis (Gout) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Gouty Arthritis (Gout) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Gouty Arthritis (Gout) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Gouty Arthritis (Gout) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Gouty Arthritis (Gout) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Gouty Arthritis (Gout) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Gouty Arthritis (Gout) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Gouty Arthritis (Gout) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Gouty Arthritis (Gout) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us